We are pleased to announce that the CAP (Cluster Randomised Trial of PSA Testing for Prostate Cancer) trial won the ONS Research Excellence Award 2018.
The award recognises excellence by a team or individual in undertaking innovative high-quality research that provides an evidence base for sound decisions supporting the formulation of effective government policies, the management of public service delivery, and the direction of economic and commercial activities. The focus is on outstanding and ground-breaking use, analysis and presentation of data, rather than just doing the job well. We were awarded the Office for National Statistics panel award, the panel highlighted the impact CAP has already had; the diverse dissemination of these results; the collaborative working practices; and the innovative methodology developed.
Dr Emma Turner presented our work Does screening for prostate cancer using the ‘PSA’ blood test save lives? The CAP Randomised Trial at the ONS Data Capability 2018 meeting where she was presented with the award. You can view the full presentation here and read the accompanying script here.
We would like to thank all our collaborators: ONS; NHS Digital; Public Health England; Welsh Cancer Intelligence and Surveillance Unit; and the Secure Anonymised Information Linkage (SAIL) databank in Swansea. We would also like to thank our funders for their continued support: Cancer Research UK; NHS National Institute for Health Research; and the Department of Health.
This work uses data provided by patients and collected by the NHS as part of their care and support #datasaveslives